Hong Kong Stock Movement | Zai Lab (09688.HK) Rises Over 7%; Clinical Data on Zoci Combined with Atezolizumab for First-Line Treatment of ES-SCLC Presented at ESMO
Zhitong Finance APP has learned that Zai Lab (09688.HK) rose more than 7%, up 4.95% as of press time, at HK$18.66, with a turnover of HK$20.6954 million.
Latest
